Wagner Scott's Form 4 filing

GoodRx Holdings, Inc. (GDRX) · filed Nov 30, 2023

Accession no.: 0001809519-23-000047
Filed: Nov 30, 2023
Trade date: Nov 28-29, 2023
Filing delay: 2 days
Rule 10b5-1 plan: Not checked

Original on SEC EDGAR (opens in a new tab)

This filing lists 2 non-derivative transactions. Open-market purchases total $180.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
Owner	Relationship to the company
Wagner ScottCIK 0001342655	Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade date	Security	Transaction	Shares	Price	Value	Shares after	Ownership	Flags
Nov 28, 2023	Class A Common Stock	PPurchaseAcquired	+4,157	$6.00^F1	+$24,942	134,900	Indirect
Nov 29, 2023	Class A Common Stock	PPurchaseAcquired	+26,348	$5.90^F3	+$155,453.2	161,248	Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.995 to $6.00, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.82 to $6.00, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Remarks

Interim Chief Executive Officer

Read the full filing on SEC EDGAR (opens in a new tab)